Skip to main content
Log in

Effect of cyclic nucleotides and of isopropylnoradrenalin on the partial pressure and consumption of oxygen

  • Pharmacology
  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

Isopropylnoradrenalin, cyclic AMP, and dibutyryl-3′,5′-AMP (DB) lower the partial pressure of oxygen (pO2) in the liver and spleen and increase the oxygen consumption of the body. The time course of these two effects for isopropylnoradrenalin and cyclic AMP correlates closely. The increase in heat production was not accompanied by any significant change in the respiratory quotient. The effects of cyclic AMP were not abolished by pempidine or by dihydroergotamine and were only reduced to some degree by propranolol. The effect of catecholamines on pO2 is evidently mediated through an increase in the O2 consumption as a result of the effect of cyclic AMP; the action of cyclic AMP is basically direct, but in vivo it cannot take place through the β adrenoreceptor; the compound 2′,3′-AMP reduces pO2 and also the O2 consumption.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literature Cited

  1. E. V. Gubler and A. A. Genkin, The Use of Nonparametric Statistical Criteria in Medical and Biological Research [in Russian], Leningrad (1966).

  2. M. M. Konstantinova and É. Ya. Graevskii, Dokl. Akad. Nauk SSSR,132, 1427 (1960).

    Google Scholar 

  3. V. I. Kulinskii, Probl. Éndokrinol., No. 5, 67 (1970).

    Google Scholar 

  4. V. I. Kulinskii and L. I. Zolochevskaya, Probl. Éndokrinol., No. 5, 61 (1974).

    Google Scholar 

  5. V. I. Kulinskii and L. S. Kolesnichenko, Vopr. Med. Khim., No. 3, 286 (1975).

    Google Scholar 

  6. V. I. Kulinskii and L. V. Trufanova, Dokl. Akad. Nauk SSSR,224, 1439 (1975).

    Google Scholar 

  7. M. D. Mashkovskii, Therapeutic Substances [in Russian], Vol. 1, Moscow (1972), p. 232.

    Google Scholar 

  8. H. M. Goodman, Proc. Soc. Exp. Biol. (New York),130, 97 (1969).

    Google Scholar 

  9. J. Himms-Hagen, in: Handbuch der experimentellen Pharmakologie, Vol. 32, Berlin (1972), p. 363.

  10. J. P. Jost and U. V. Rickenberg, Ann. Rev. Biochem.,40, 750 (1971).

    Google Scholar 

  11. R. A. Levine, S. E. Lewis, J. Shulman, et al., J. Biol. Chem.,244, 4017 (1969).

    Google Scholar 

  12. R. A. Levine and J. A. Vogel, J. Pharmacol. Exp. Ther.,151, 262 (1966).

    Google Scholar 

  13. W. L. Ryan and M. A. Durick, Science,177, 1002 (1972).

    Google Scholar 

  14. R. Starcich, F. Barbaresi, G. Volta, et al., Minerva Cardioangiol.,15, 844 (1967).

    Google Scholar 

  15. O. Strubelt, in: FEBS, 6th Meeting, Vol. 19, Madrid (1970), p. 156.

  16. A. Tsujumoto, S. Tanino, T. Nishiue, et al., Jpn. J. Pharmacol.,15, 441 (1965).

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kulinskii, V.I., Kovalevskii, A.N. Effect of cyclic nucleotides and of isopropylnoradrenalin on the partial pressure and consumption of oxygen. Bull Exp Biol Med 83, 181–184 (1977). https://doi.org/10.1007/BF00799416

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00799416

Key Words

Navigation